PROGNOSTIC IMPACT OF QUALITY OF RESPONSE IN PATIENTS WITH MULTIPLE MYELOMA RECEIVING UP-FRONT THALIDOMIDE-DEXAMETHASONE AND DOUBLE AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT)